コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 thyroid hormone in the brain-dead potential organ donor.
2 tigations, LCMV could not be detected in the organ donor.
3 between the transplant surgeon and the live-organ donor.
4 source of the West Nile virus viremia in the organ donor.
5 and age-dependent probability of becoming an organ donor.
6 willingness of individuals to be a deceased organ donor.
7 C patients, compared to control samples from organ donors.
8 psychosocial evaluation for eligible living organ donors.
9 mucosal tissues obtained from 56 individual organ donors.
10 rs per 100 eligible deaths were converted to organ donors.
11 A total of 119 patients became actual organ donors.
12 nt screening practices of potential deceased organ donors.
13 explained etiology, especially for potential organ donors.
14 work database from 2000 to 2012 of all solid organ donors.
15 tive than NAT for the screening of potential organ donors.
16 in kidney allograft recipients and deceased organ donors.
17 , particularly when patients were registered organ donors.
18 n of thyroid hormone to brain-dead potential organ donors.
19 from DCD and donors after brain death (DBD) organ donors.
20 ations for screening and management of TB in organ donors.
21 ght patients with CHI and from adult cadaver organ donors.
22 ancreas was not recovered in 48% (11,820) of organ donors.
23 1 may serve to increase the pool of eligible organ donors.
24 btained from the knee and ankle joints of 34 organ donors.
25 ation today is how to increase the number of organ donors.
26 a series of 10,000 consecutive UK cadaveric organ donors.
27 d, the main difficulty being the shortage of organ donors.
28 Two mothers also became organ donors.
29 ganizations to identify brain-dead potential organ donors.
30 hand) was performed in 9 human heart-beating organ donors.
31 ust be developed to exclude CMV from porcine organ donors.
32 ogressively outstripping the availability of organ donors.
33 ths of patients who became non-heart-beating organ donors.
34 e of tone in human LES samples obtained from organ donors.
35 he 100 experimental animals could be used as organ donors.
36 different anatomic compartments in six human organ donors.
37 Upper limbs were procured from brain-dead organ donors.
38 acini isolated from cadaveric pancreata from organ donors.
39 n regarding the number of potential deceased organ donors.
40 disc cells isolated from healthy, pain-free organ donors.
41 ry (registrants) and their value in terms of organ donors.
42 e compared with those from three nondiabetic organ donors.
43 the DonateLife Audit of whom 553 (8.1%) were organ donors.
44 nt psychosocial screening programs of living organ donors.
45 there continues to be a critical shortage of organ donors.
46 quency of false-positive results in deceased organ donors.
47 possible to estimate the expected number of organ donors.
48 ific for the identification of survivors and organ donors.
49 tines) sites from a population of brain-dead organ donors (2 months-93 years; n = 291) across eight c
50 f T. cruzi antibodies in Southern California organ donors, 404 samples from deceased organ donors bet
54 plant recipients developed encephalitis from organ donor-acquired lymphocytic choriomeningitis virus.
58 pothermia, as compared with normothermia, in organ donors after declaration of death according to neu
60 improve the identification and reporting of organ donors aiming at an annual rate of 15 donors per m
65 ebrospinal fluid, and urine samples from the organ donor and recipients were tested for WNV infection
66 es have the potential to instrumentalize the organ donor and that they should be restricted to cases
69 To minimize variables associated with the organ donor and with tissue processing, all of the graft
71 ed from pancreata procured from 12 cadaveric organ donors and cultured in the M-SFM for up to 2 month
72 nce of anti-HTLV I/II antibodies among solid organ donors and determine the number of false positive
73 atory response characteristics in brain-dead organ donors and examine associations with organ transpl
74 obtained from nonfailing hearts of unmatched organ donors and failing hearts at the time of transplan
75 tic digestion from normal ankle cartilage of organ donors and from osteoarthritic (OA) knee tissue ob
76 eload responsiveness is common in brain-dead organ donors and is associated with higher inflammatory
79 ntation offers a solution to the shortage of organ donors and may offer resistance to human-specific
80 We characterized CD8 T cells derived from organ donors and patients with end-stage HCV infection t
81 HHV-8 status can be useful when considering organ donors and recipients with risk factors, although
82 However, the extreme shortage of matched organ donors and the necessity for chronic immunosuppres
83 try needs to increase the number of deceased organ donors and the potential impact of a change to opt
85 cs and risk factors for ZIKV infection among organ donors and transplant outcomes among recipients of
86 sues were selected from groups of nonfailing organ donors and transplant recipients with endstage isc
87 in human islets obtained from deceased adult organ donors and transplanted them into hyperglycemic, i
88 NV infections among recipients from the same organ donor, and remove any potentially infected blood p
89 ent acquisition of HIV by prospective living organ donors, and to conduct HIV antibody testing and NA
90 were also those who would be unlikely to be organ donors anyway, because they tended to hold negativ
91 for such studies and the fact that deceased organ donors are not covered by extant federal regulatio
94 policy requires that all potential deceased organ donors are screened for human immunodeficiency (HI
100 n-dead patients who became non-heart-beating organ donors at the University of Pittsburgh Medical Cen
102 tions related to management of the potential organ donor, based on the available literature and exper
104 from the costal diaphragms of 14 brain-dead organ donors before organ harvest (case subjects) and co
105 The effect that targeted mild hypothermia in organ donors before organ recovery has on the rate of de
108 rnia organ donors, 404 samples from deceased organ donors between May 2002 to April 2004 were screene
111 Hormonal therapy to the brain-dead potential organ donor can include thyroid hormone (triiodothyronin
113 from patients undergoing transplantation or organ donors (CF samples=18; non-CF, nonbronchiectatic s
115 ernment in the past, its implications on the organ donor consent process, and its potential impact on
117 be applied at any institution with access to organ donors consenting to tissue donation for research,
118 nsplants, the suitability of pancreases from organ donors considered inappropriate for pancreas trans
121 e status of both the organ recipient and the organ donor critically influences allograft outcome.
122 periences of brief cardiopulmonary arrest in organ donors did not affect post-OLT hepatic allograft s
123 liver, and an arterial segment from a common organ donor died of encephalitis of an unknown cause.
124 and lymphoid tissues of T1D and nondiabetic organ donors differ in the amount and distribution of HA
125 mposition of the national pool of brain-dead organ donors during a three-year period and, on the basi
129 In conclusion, these data suggest that prior organ donors experience brief waiting time for kidney tr
130 lear cause of death in a potential pediatric organ donor, factors such as parental consanguinity shou
131 mission of melanoma by apparent disease-free organ donors following removal of a primary melanoma up
132 seeking organ transplantation and serving as organ donors for HIV-positive recipients, HHV-8 prevalen
143 tion (CPR) of a person destined to become an organ donor has been associated with overall poor donor
148 The decline in heart-beating brainstem dead organ donors has necessitated the search for other organ
151 o represent an underused source of potential organ donors; however, there is a paucity of data regard
152 ct to ICOD were finally medically unsuitable organ donors.ICOD contributed to 24% of the 491 actual d
153 imary outcome measure was potential deceased organ donors (identified by the presence of diagnostic c
156 kistan, Egypt, and the Philippines, deceased organ donors in Colombia, and executed prisoners in Chin
158 ucosal tissue T cells derived from pediatric organ donors in the first two years of life, as compared
160 .8 per million of population [pmp]) deceased organ donors in the United Kingdom from 1999 to 2009.
162 2013 modification, over 20% of all deceased organ donors in the United States were identified as PHS
164 g (RNA-seq) on islets from multiple deceased organ donors, including children, healthy adults, and in
167 nt or undiagnosed active TB in the potential organ donor is critical to prevent emergence of disease
170 virus type 1 (HTLV-1) screening of blood and organ donors is not mandatory in Germany because of its
172 nor's participation in the study, ended when organ donors left the intensive care unit for organ reco
175 after brain stem herniation in 980 potential organ donors managed by the California Transplant Donor
178 Many of the common ECG abnormalities seen in organ donors may result from the heightened state of sym
179 increasing the willingness to be a deceased organ donor (measured as commitment to donate and/or int
181 l profit." Christian authorities insist that organ donors must not accrue economic advantage, and "se
186 0.32-0.53; p < 0.001), more often potential organ donors (odds ratio, 1.92; 95% CI, 1.56-2.35; p < 0
189 Last year, from the approximately 6,000 organ donors, only approximately 1,500 pancreata were us
190 er gram of human liver (n = 6) obtained from organ donors or directly from surgery is, on average, le
191 acute rejection response, we used Tg mice as organ donors or recipients of MHC-incompatible heart gra
192 about the expected ECG findings in potential organ donors or the clinical significance of any identif
193 ning hundreds of thousands of cells in human organ donor pancreata, we show that quantitative graph c
196 rs has been used at our center to expand the organ donor pool and decrease the waiting time for decea
197 novel therapeutic approaches to maximize the organ donor pool through the safer use of liver transpla
198 novel therapeutic approaches to maximize the organ donor pool through the safer use of liver transpla
200 t of recommendations aimed at maximizing the organ donor pool while safeguarding the interests of pot
201 f IRI, to improve liver function, expand the organ donor pool, and improve the overall success of liv
202 tion: shorter waiting time, expansion of the organ donor pool, and improved short-term and long-term
204 to improve organ function and to expand the organ donor pool, problems still exist with the current
205 on or strategies to increase the size of the organ donor pool, such as xenotransplantation, are neede
213 eas transplant but because of differences in organ donor, recipient, and transplant characteristics.
214 ering the absence of systematic screening of organ donors/recipients for HHV-8 infection, HHV-8-relat
217 ue Act (2004) should be removed, and (7) the Organ Donor Register should be expanded to include poten
219 , motivated 19 623 people to go to a state's organ donor registration page, and had 9000 documented o
224 d seven hundred eight individuals joined the organ donor registry (95% confidence interval [95% CI],
225 -based educational interventions to increase organ donor registry participation and family notificati
227 In 2000, the Consensus Statement on the Live Organ Donor reported that "direct financial compensation
228 luded if they were declared brain dead, were organ donors, required high-frequency ventilation, or if
230 irst two years of life, as compared to adult organ donors, revealing early compartmentalization of T
231 and mucosal tissues obtained from individual organ donors, revealing tissue-intrinsic compartmentaliz
234 d1 in total liver RNA extracted from cadaver organ donor samples from reduced human grafts and explan
235 ent pulmonary autograft surgery and 8 normal organ donors, samples from the PA and aorta were analyze
236 hirty-two of 3,555 (0.9%) potential deceased organ donors screened during the study period showed a p
242 ure (FHF), but its use is limited because of organ donor shortage, associated high costs, and the req
245 Notwithstanding the widely acknowledged organ-donor shortage coupled with the expanded waiting l
250 testing (NAT) for the screening of potential organ donors should be reserved to high-risk donors.
253 dance is made the dominant principle guiding organ donor testing, an unintended consequence may be an
255 f a severe shortage of kidneys from deceased organ donors that limits access to transplantation for m
256 S) changed the criteria intended to identify organ donors that put the associated organ recipients at
257 the liver function tests are elevated in an organ donor, the hepatic allograft is suitable for OLT i
258 Compared with the standard risk deceased organ donor, the PHS donor was younger, male, died from
259 012, 96,028 (3.3%) were a "possible deceased-organ donor." The two proposed metrics of OPO performanc
261 ing the transmission of rabies virus from an organ donor to multiple recipients underscores the chall
262 lower esophageal sphincter (N-LES) of human organ donors to examine the physiologic signal transduct
263 rt the concept of extending the criteria for organ donors to include modest coronary atherosclerosis.
264 d, iliac artery grafts procured from cadaver organ donors to reconstruct transplant renal arteries in
265 ding death and appropriately refer potential organ donors to the local organ procurement organization
267 rospective longitudinal observation study of organ donors treated at a major metropolitan level I tra
270 on the previous transplant procedure and the organ donor was obtained from the Eurotransplant Foundat
272 ts' knowledge about how to register to be an organ donor was the dominant dimension for donor registr
274 ctional hemodynamic monitoring in brain-dead organ donors, we test the hypothesis that donor preload
275 Two additional recipients from the same organ donor were identified, their clinical and exposure
277 from pubertal and adult age group cadaveric organ donors were harvested and profiled using 20,000 el
279 e focused on increasing the number of living organ donors, which in 2001 for the first time exceeded
280 t influence individuals' decisions to become organ donors, which may be effectively targeted by inter
282 islets from six DiViD study patients and two organ donors who died at the onset of T1D, and the findi
285 nd biceps specimens obtained from brain-dead organ donors who underwent MV (15-176 h) and age-matched
286 8-month-old rats and in human islets from 53 organ donors with ages ranging from 17 to 74 years.
287 ude patients from the Network for Pancreatic Organ Donors with Diabetes (U.S.) and Diabetes Virus Det
293 gical examination of pancreata from diabetic organ donors with the goal of providing a foundation for
294 alpha-cell mass in pancreata recovered from organ donors with type 1 diabetes (n = 80), as well as f
295 om inflamed pancreatic islets of three young organ donors with type 1 diabetes with a short disease d
296 Examination of pancreata from age-matched organ donors with type 2 diabetes mellitus (DM) treated
297 y six times higher than the number of actual organ donors, with the greatest loss of potential due to
298 vasopressin deficiency in hypotensive solid organ donors without clinical evidence of diabetes insip
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。